全球化学品在线数据库
| CAS 登录号 | 产品名称 | 分子式 |
|---|---|---|
| 1252686-29-5 | tert-butyl (S)-(1-(4-ethoxyphenyl)-3-hydroxypropan-2-yl)carbamate;tert-butyl N-[(2S)-1-(4-ethoxyphenyl)-3-hydroxypropan-2-yl]carbamate | C16H25NO4 |
| 1252761-56-0 | (4R)-4-(3,4-Dichlorophenyl)-2-pyrrolidinone | C10H9Cl2NO |
| 1252782-43-6 | 4-Fluoro-1H-indole-5-carboxylic acid methyl ester | C10H8FNO2 |
| 1252883-90-1 | N-Methyl-N-[(3S,4S)-4-methyl-1-(phenylmethyl)-3-piperidinyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine | C20H25N5 |
| 1252914-52-5 | N-Phenyl-4-dibenzothiophenamine | C18H13NS |
| 1252934-30-7 | 3-(Bromomethyl)-1,1-difluorocyclobutane | C5H7BrF2 |
| 1253055-87-6 | 6-Cyclopropylpyridine-3-boronic acid;B-(6-Cyclopropyl-3-pyridinyl)boronic acid | C8H10BNO2 |
| 1253055-92-3 | Methyl 3-amino-4-(2,4,5-trifluorophenyl)butanoate | C11H12F3NO2 |
| 1253056-01-7 | Sitagliptin Hydroxy Amide Impurity;3-hydroxy-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)butan-1-one | C16H14F6N4O2 |
| 1253056-18-6 | (2E)-1-[5,6-Dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluorophenyl)-2-buten-1-one | C16H12F6N4O |
| 1253282-31-3 | Fmoc-Aph(Hor)-OH;(2S)-3-[4-[[(4S)-2,6-dioxo-1,3-diazinane-4-carbonyl]amino]phenyl]-2-(9H-fluoren-9-ylmethoxycarbonylamino)propanoic acid; 4-({[(4S)-2,6-Dioxohexahydro-4-pyrimidinyl]carbonyl}amino)-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-phenylalanine | C29H26N4O7 |
| 1253291-12-1 | [4-(Difluoromethoxy)-3-[2-(2-pyridinyl)ethynyl]phenyl](5,7-dihydro-6H-pyrrolo[3,4-b]pyridin-6-yl)methanone;GRN 529 | C22H15F2N3O2 |
| 1253452-78-6 | N-[4-(2-Hydroxyethyl)phenyl]-2-[(4-nitrobenzoyl)amino]benzamide | C22H19N3O5 |
| 1253584-84-7 | 5-[2,4-Dihydroxy-6-(4-nitrophenoxy)phenyl]-N-(1-methyl-4-piperidinyl)-3-isoxazolecarboxamide;NMS-E 973 | C22H22N4O7 |
| 1253654-79-3 | 4,6-Dichloro-3-methylisoxazolo[5,4-d]pyrimidine | C6H3Cl2N3O |
| 1253654-82-8 | 8-Nitro-4-oxo-4H-1-benzopyran-3-carboxaldehyde | C10H5NO5 |
| 1253730-25-4 | 3-Oxetaneethanamine | C5H11NO |
| 1253789-67-1 | tert-Butyl (5-phenylpyrrolidin-3-yl)carbamate | C15H22N2O2 |
| 1253790-61-2 | 5-Amino-1-methyl-1H-pyrazole-3-carboxylic acid ethyl ester hydrochloride | C7H11N3O2.HCl |
| 1253792-57-2 | 5,6,7,8-Tetrahydro-1,7-naphthyridine-3-carboxylic acid methyl ester hydrochloride | C10H12N2O2.HCl |
| 1253792-86-7 | (4S)-rel-4-[[(1,1-Dimethylethoxy)carbonyl]amino]-D-proline methyl ester | C11H20N2O4 |
| 1253799-29-9 | 3-[Bis(phenylmethyl)amino]-5-fluoro-6-methyl-2-(phenylmethoxy)benzoic acid phenyl ester | C35H30FNO3 |
| 1253888-80-0 | 5,6,7,8-Tetrahydro-1,7-naphthyridine-3-carboxylic acid methyl ester | C10H12N2O2 |
| 1253912-15-0 | (2,3-Dihydro-1H-indol-6-yl)boronic acid | C8H10BNO2 |
| 1253952-02-1 | 2,4-Dimethylbenzoic acid [4-[(1S)-1-(aminomethyl)-2-(6-isoquinolinylamino)-2-oxoethyl]phenyl]methyl ester hydrochloride (1:2) | C28H27N3O3.2(HCl) |
| 1254036-66-2 | rel-N-[5-[4-[5-[[(2R,6S)-2,6-Dimethyl-4-morpholinyl]methyl]-2-oxazolyl]-1H-indazol-6-yl]-2-methoxy-3-pyridinyl]methanesulfonamide | C24H28N6O5S |
| 1254036-77-5 | 6-(1H-Indol-4-yl)-4-[5-[[4-(1-methylethyl)-1-piperazinyl]methyl]-2-oxazolyl]-1H-indazole hydrochloride (1:1) | C26H28N6O.HCl |
| 1254053-43-4 | Gilteritinib;6-Ethyl-3-[[3-methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]amino]-5-[(tetrahydro-2H-pyran-4-yl)amino]-2-pyrazinecarboxamide; ASP 2215 | C29H44N8O3 |
| 1254053-84-3 | Gilteritinib fumarate;ASP 2215 hemifumarate | 2(C29H44N8O3).C4H4O4 |
| 1254115-16-6 | 4-Fluoro-4-piperidinemethanol hydrochloride | C6H12FNO.HCl |
| 1254115-23-5 | 1-(3-Oxetanyl)piperazine | C7H14N2O |
| 1254205-52-1 | 4-[[[3-Chloro-5-(trifluoromethyl)-2-pyridinyl][[4-(trifluoromethoxy)phenyl]methyl]amino]sulfonyl]benzoic acid | C21H13ClF6N2O5S |
| 1254251-27-8 | (2S)-2-Aminoundecanoic acid | C11H23NO2 |
| 1254276-84-0 | (Z)-[2-{(3R,4R,5R)-3,5-bis(tert-butyldimethylsilanyloxy)-2-methylene-4-(3-(tert-butyldiphenylsilanyloxy)propoxy)cyclohexylidene}ethyl]diphenylphosphine oxide;Eldecalcitol Intermediate | C52H75O5PSi3 |
| 1254319-51-1 | 6-bromo-2-methyl-2,3-dihydro-1H-isoindol-1-one | C9H8BrNO |
| 1254319-55-5 | 3-Bromo-6-methyl-5,6-dihydro-pyrrolo[3,4-b]pyridin-7-one | C8H7BrN2O |
| 1254353-37-1 | 5,6-Bis(octyloxy)-2,1,3-benzothiadiazole | C22H36N2O2S |
| 1254473-64-7 | 4-[(1E)-2-[5-[(1R)-1-(3,5-Dichloro-4-pyridinyl)ethoxy]-1H-indazol-3-yl]ethenyl]-1H-pyrazole-1-ethanol | C21H19Cl2N5O2 |
| 1254473-66-9 | 3,5-Dichloro-alpha-methyl-4-pyridinemethanol | C7H7Cl2NO |
| 1254576-93-6 | Diclofenac 2,5-Quinone Imine;5-Hydroxydiclofenac quinone imine | C14H9Cl2NO3 |
| 1254694-56-8 | 2-Bromo-4-methylthiazole-5-carboxamide | C5H5BrN2OS |
| 1254955-21-9 | N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-butenamide hydrochloride (1:?) | C24H25ClFN5O3.x(HCl) |
| 1254977-87-1 | 3-(Cyclopropylmethyl)-7-(4-phenyl-1-piperidinyl)-8-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyridine;JNJ 42153605 | C22H23F3N4 |
| 1255098-56-6 | 6,6-Dimethyl-3-morpholinecarboxylic acid methyl ester | C8H15NO3 |
| 1255098-88-4 | Sodium 1,3-oxazole-2-carboxylate | C4H2NNaO3 |
| 1255208-17-3 | 6-Ethenyl-4-methoxypyridine-3-carbonitrile | C9H8N2O |
| 1255308-97-4 | 5H-[1]Benzothieno[3,2-c]carbazole | C18H11NS |
| 1255309-13-7 | 4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-YL)-9H-carbazole | C18H20BNO2 |
| 1255502-07-8 | (3R)-3,5-Dihydroxy-3-methylpentanoic acid lithium salt (1:1) | C6H11O4.Li |
| 1255517-76-0 | 2-[[4-(5-Ethyl-4-pyrimidinyl)-1-piperazinyl]methyl]-6-(trifluoromethyl)-1H-benzimidazole | C19H21F3N6 |